5,258 Astera Labs, Inc. $ALAB Shares Acquired by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund boosted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 19.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 32,819 shares of the company’s stock after purchasing an additional 5,258 shares during the period. Illinois Municipal Retirement Fund’s holdings in Astera Labs were worth $11,683,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Greenleaf Trust increased its holdings in shares of Astera Labs by 1.8% in the second quarter. Greenleaf Trust now owns 2,000 shares of the company’s stock worth $966,000 after buying an additional 36 shares during the period. Parkside Financial Bank & Trust lifted its stake in shares of Astera Labs by 74.5% in the 2nd quarter. Parkside Financial Bank & Trust now owns 96 shares of the company’s stock valued at $46,000 after acquiring an additional 41 shares during the last quarter. Integrated Advisors Network LLC lifted its stake in shares of Astera Labs by 4.8% in the 3rd quarter. Integrated Advisors Network LLC now owns 983 shares of the company’s stock valued at $350,000 after acquiring an additional 45 shares during the last quarter. Interchange Capital Partners LLC boosted its holdings in Astera Labs by 4.4% during the 3rd quarter. Interchange Capital Partners LLC now owns 1,187 shares of the company’s stock valued at $423,000 after acquiring an additional 50 shares during the period. Finally, Glenmede Trust Co. NA boosted its holdings in Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock valued at $209,000 after acquiring an additional 51 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Key Headlines Impacting Astera Labs

Here are a few of the latest headlines about ALAB:

• Positive Sentiment: Northland raised its FY2026 EPS estimate to $2.99 from $2.75 and its Q4 2026 estimate to $1.25 from $1.09, while maintaining an Outperform rating and $315 price target. Analyst estimate details
• Neutral Sentiment: Astera Labs announced it will participate in the BMO Technology and Innovation Leaders Conference on Nov. 12. The announcement provides a forum for company updates but did not disclose new business or financial information. Conference announcement
• Negative Sentiment: ETFs were net sellers of $80.2 million of ALAB in the Nov. 6 session, indicating notable fund outflows that may add selling pressure. ETF selling report

Insiders Place Their Bets

In other news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares of the company’s stock, valued at approximately $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of the business’s stock in a transaction that occurred on Thursday, November 5th. The shares were sold at an average price of $211.41, for a total value of $1,901,421.54. Following the transaction, the director directly owned 1,987 shares in the company, valued at $420,071.67. This trade represents a 81.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 408,558 shares of company stock worth $126,050,884. Insiders own 10.40% of the company’s stock.

Wall Street Analysts Forecast Growth

ALAB has been the topic of several recent research reports. Northland Securities upgraded Astera Labs from a “market perform” rating to an “outperform” rating and set a $315.00 price target on the stock in a research report on Wednesday, November 4th. Barclays boosted their price objective on Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research report on Monday, July 20th. Morgan Stanley increased their price objective on Astera Labs from $382.00 to $389.00 and gave the company an “overweight” rating in a research note on Wednesday, November 4th. TD Cowen cut their target price on shares of Astera Labs from $300.00 to $225.00 and set a “hold” rating on the stock in a report on Wednesday, November 4th. Finally, Wall Street Zen raised shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Thirteen equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $320.85.

Astera Labs Trading Up 6.8%

Shares of NASDAQ:ALAB opened at $230.91 on Thursday. The company has a market cap of $40.36 billion, a price-to-earnings ratio of 92.00 and a beta of 3.85. The company has a 50-day moving average price of $296.41 and a 200-day moving average price of $256.51. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 3rd. The company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a return on equity of 25.35% and a net margin of 29.64%. The company had revenue of $584.90 million for the quarter, compared to analysts’ expectations of $550.78 million. During the same period last year, the firm earned $0.49 earnings per share. Astera Labs’s quarterly revenue was up 153.6% on a year-over-year basis. As a group, research analysts forecast that Astera Labs, Inc. will post 2.99 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.